Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C.

Konishi M, Iwasa M, Yamauchi K, Sugimoto R, Fujita N, Kobayashi Y, Watanabe S, Teraguchi S, Adachi Y, Kaito M.

Hepatol Res. 2006 Sep;36(1):27-32. Epub 2006 Jul 20.

PMID:
16857423
2.

Dose-response trial of lactoferrin in patients with chronic hepatitis C.

Okada S, Tanaka K, Sato T, Ueno H, Saito S, Okusaka T, Sato K, Yamamoto S, Kakizoe T.

Jpn J Cancer Res. 2002 Sep;93(9):1063-9.

PMID:
12359061
3.

Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C.

Ueno H, Sato T, Yamamoto S, Tanaka K, Ohkawa S, Takagi H, Yokosuka O, Furuse J, Saito H, Sawaki A, Kasugai H, Osaki Y, Fujiyama S, Sato K, Wakabayashi K, Okusaka T.

Cancer Sci. 2006 Oct;97(10):1105-10.

4.

Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months.

Ishii K, Takamura N, Shinohara M, Wakui N, Shin H, Sumino Y, Ohmoto Y, Teraguchi S, Yamauchi K.

Hepatol Res. 2003 Mar;25(3):226-233.

PMID:
12697243
5.
6.

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.

Ikeda M, Sugiyama K, Tanaka T, Tanaka K, Sekihara H, Shimotohno K, Kato N.

Biochem Biophys Res Commun. 1998 Apr 17;245(2):549-53.

PMID:
9571193
7.
8.

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

Ikeda M, Nozaki A, Sugiyama K, Tanaka T, Naganuma A, Tanaka K, Sekihara H, Shimotohno K, Saito M, Kato N.

Virus Res. 2000 Jan;66(1):51-63.

PMID:
10653917
9.

Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.

Mahmood S, Yamada G, Niiyama G, Kawanaka M, Togawa K, Sho M, Ito T, Sasagawa T, Okita M, Nakamura H, Yodoi J.

Free Radic Res. 2003 Jul;37(7):781-5.

PMID:
12911275
10.

Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis.

Yamano E, Miyauchi M, Furusyo H, Kawazoe A, Ishikado A, Makino T, Tanne K, Tanaka E, Takata T.

Lab Invest. 2010 Aug;90(8):1236-46. doi: 10.1038/labinvest.2010.80. Epub 2010 Apr 26.

11.

Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C.

Yoshida Y, Imai Y, Sawai Y, Saito Y, Cao J, Fukuda K, Niki E.

J Gastroenterol Hepatol. 2010 Jan;25(1):107-15. doi: 10.1111/j.1440-1746.2009.05928.x. Epub 2009 Sep 25.

PMID:
19780883
12.
13.

Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.

Chien YJ, Chen WJ, Hsu WL, Chiou SS.

Virology. 2008 Sep 15;379(1):143-51. doi: 10.1016/j.virol.2008.06.017. Epub 2008 Jul 21.

14.
15.

Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.

Lin TJ, Liao LY, Chou JM, Liu SO, Wang CK.

Hepatogastroenterology. 2009 Jul-Aug;56(93):1146-51.

PMID:
19760959
16.

Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.

Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B.

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):95-101.

PMID:
16445706
17.

[Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment].

Bolewska B, Wojtacha A, Juszczyk J, Przedwojewski M.

Pol Merkur Lekarski. 2005 May;18(107):552-5. Polish.

PMID:
16161954
18.

Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production.

Zimecki M, Miedzybrodzki R, Szymaniec S.

Arch Immunol Ther Exp (Warsz). 1998;46(6):361-5.

PMID:
9883315
19.

A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.

Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, Kato J, Iino S, Yotsuyanagi H, Kobayashi Y, Kawamura K, Kakumu S, Kaito M, Ikoma J, Wakusawa S, Okanoue T, Sumida Y, Kimura F, Kajiwara E, Sata M, Ogata K.

J Gastroenterol. 2004 Jun;39(6):570-4.

PMID:
15235875
20.

Supplemental Content

Support Center